414 related articles for article (PubMed ID: 36682020)
21. Diagnostic Value of
Feng L; Yang X; Lu X; Kan Y; Wang C; Zhang H; Wang W; Yang J
Acad Radiol; 2023 May; 30(5):940-951. PubMed ID: 36117128
[TBL] [Abstract][Full Text] [Related]
22. A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma.
Peng J; Zou D; Zhang X; Ma H; Han L; Yao B
J Transl Med; 2024 Jan; 22(1):87. PubMed ID: 38254087
[TBL] [Abstract][Full Text] [Related]
23.
Qian LD; Feng LJ; Zhang SX; Liu J; Ren JL; Liu L; Zhang H; Yang J
Quant Imaging Med Surg; 2023 Jan; 13(1):94-107. PubMed ID: 36620179
[TBL] [Abstract][Full Text] [Related]
24. Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma.
Gong XQ; Liu N; Tao YY; Li L; Li ZM; Yang L; Zhang XM
Sci Rep; 2023 May; 13(1):7710. PubMed ID: 37173350
[TBL] [Abstract][Full Text] [Related]
25.
Xue XQ; Yu WJ; Shi X; Shao XL; Wang YT
Front Oncol; 2022; 12():911168. PubMed ID: 36003788
[TBL] [Abstract][Full Text] [Related]
26. Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images.
Mu W; Jiang L; Shi Y; Tunali I; Gray JE; Katsoulakis E; Tian J; Gillies RJ; Schabath MB
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34135101
[TBL] [Abstract][Full Text] [Related]
27. Predictive value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for PD-L1 expression in non-small cell lung cancer: A systematic review and meta-analysis.
Seol HY; Kim YS; Kim SJ
Thorac Cancer; 2020 Nov; 11(11):3260-3268. PubMed ID: 32951338
[TBL] [Abstract][Full Text] [Related]
28. Performance of
Zhang M; Bao Y; Rui W; Shangguan C; Liu J; Xu J; Lin X; Zhang M; Huang X; Zhou Y; Qu Q; Meng H; Qian D; Li B
Front Oncol; 2020; 10():568857. PubMed ID: 33134170
[TBL] [Abstract][Full Text] [Related]
29. Assessing PD-L1 Expression Level by Radiomic Features From PET/CT in Nonsmall Cell Lung Cancer Patients: An Initial Result.
Jiang M; Sun D; Guo Y; Guo Y; Xiao J; Wang L; Yao X
Acad Radiol; 2020 Feb; 27(2):171-179. PubMed ID: 31147234
[TBL] [Abstract][Full Text] [Related]
30. A Machine Learning Approach Using PET/CT-based Radiomics for Prediction of PD-L1 Expression in Non-small Cell Lung Cancer.
Lim CH; Koh YW; Hyun SH; Lee SJ
Anticancer Res; 2022 Dec; 42(12):5875-5884. PubMed ID: 36456151
[TBL] [Abstract][Full Text] [Related]
31. An 18F-FDG-PET/CT-based radiomics signature for estimating malignance probability of solitary pulmonary nodule.
Zheng J; Hao Y; Guo Y; Du M; Wang P; Xin J
Clin Respir J; 2024 May; 18(5):e13751. PubMed ID: 38725315
[TBL] [Abstract][Full Text] [Related]
32. Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer.
Meißner AK; Gutsche R; Galldiks N; Kocher M; Jünger ST; Eich ML; Nogova L; Araceli T; Schmidt NO; Ruge MI; Goldbrunner R; Proescholdt M; Grau S; Lohmann P
J Neurooncol; 2023 Jul; 163(3):597-605. PubMed ID: 37382806
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity and specificity of amide proton transfer-weighted imaging for assessing programmed death-ligand 1 status in non-small cell lung cancer: a comparative study with intravoxel incoherent motion and
Meng N; Fu F; Sun J; Feng P; Luo Y; Wu Y; Li X; Yuan J; Yang Y; Liu H; Wang Z; Wang M
Quant Imaging Med Surg; 2022 Sep; 12(9):4474-4487. PubMed ID: 36060584
[TBL] [Abstract][Full Text] [Related]
34. PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.
Yang L; Xu P; Li M; Wang M; Peng M; Zhang Y; Wu T; Chu W; Wang K; Meng H; Zhang L
Front Oncol; 2022; 12():894323. PubMed ID: 35800046
[TBL] [Abstract][Full Text] [Related]
35. Radiomics analysis of [
Li Y; Zhang Y; Fang Q; Zhang X; Hou P; Wu H; Wang X
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2599-2614. PubMed ID: 33416951
[TBL] [Abstract][Full Text] [Related]
36.
Xu X; Sun X; Ma L; Zhang H; Ji W; Xia X; Lan X
Front Oncol; 2023; 13():1149791. PubMed ID: 36969043
[TBL] [Abstract][Full Text] [Related]
37. Value of computed tomography radiomics combined with inflammation indices in predicting the efficacy of immunotherapy in patients with locally advanced and metastatic non-small cell lung cancer.
Shao H; Zhu J; Shi L; Yao J; Wang Y; Ma C; Swierniak A; Ni B
J Thorac Dis; 2024 May; 16(5):3213-3227. PubMed ID: 38883654
[TBL] [Abstract][Full Text] [Related]
38. Development and Validation of a Radiomics Nomogram Based on
Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
Front Oncol; 2020; 10():1042. PubMed ID: 32766134
[No Abstract] [Full Text] [Related]
39. A CT-based radiomics signature for preoperative discrimination between high and low expression of programmed death ligand 1 in head and neck squamous cell carcinoma.
Zheng YM; Zhan JF; Yuan MG; Hou F; Jiang G; Wu ZJ; Dong C
Eur J Radiol; 2022 Jan; 146():110093. PubMed ID: 34890937
[TBL] [Abstract][Full Text] [Related]
40.
Wang J; Zheng Z; Zhang Y; Tan W; Li J; Xing L; Sun X
Front Oncol; 2023; 13():1185808. PubMed ID: 37546415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
